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Background: Iron supplementation is a common recommendation for pregnant women to prevent iron deficiency
during pregnancy. There is an increasing concern about excessive iron consumption as a general iron prophylaxis
by pregnant women without any due consideration about their dietary iron intake or iron status. Our present study
investigated the association between total iron intake from diet and supplements and fetal growth in 337 pregnant
women at mid-pregnancy in South Korea.
Methods: Iron intake from diet and supplements was examined by a 24-hour recall method. Subjects were divided
into three groups based on tertiles of total iron intake levels. Fetal biometry was assessed by ultrasonography at
mid-pregnancy.
Results: About 99% of the non-supplement users had iron intake below the recommended nutrient intake (RNI) for
pregnant women (24 mg), whereas 64.9% of supplement users had iron intake above the upper level (UL) (45 mg).
In the babies of mothers in the third tertile of iron intake (>17.04 mg), biparietal diameter, abdominal
circumference, and femur length were lower by 0.41 cm (P =0.019), 0.41 cm (P = 0.027), and 0.07 cm (P = 0.051),
respectively, than the babies of mothers in the second tertile of iron intake (11.49 ~ 17.04 mg).
Conclusion: These results suggest that excessive maternal iron intake at mid-pregnancy is associated with reduced
fetal growth. Iron supplementation for pregnant women should be individualized according to their iron status.
Appropriate diet education is needed for pregnant women so that they can consume adequate amounts of iron
from food and supplements.
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Maternal iron status has been a critical factor for preg-
nancy outcomes, because maternal anemia as well as
iron deficiency increases the risk of adverse pregnancy
outcomes such as preterm delivery [1] and low birth
weight [2]. Although iron supplementation is a common
recommendation for pregnant women to prevent iron* Correspondence: nschang@ewha.ac.kr
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reproduction in any medium, provided the ordeficiency during pregnancy, the beneficial effects of
general iron supplementation on pregnancy outcomes
are a controversial issue [3,4].
Until the past 10 years or so, the risk of iron deficiency
in Korean pregnant women was high with a prevalence
of ~20% [5,6] and a number of reports are available on
inverse association between maternal iron status and
pregnancy outcomes [7-10]. Recently, there has been an
increasing concern that pregnant women in Korea might
be consuming excessive iron from supplements without
considering their dietary iron intake or iron status. A re-
cent survey has reported that 30 – 40% of KoreanLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dietary supplements [11] and 47.3% of supplement users
took supplements on their own, without any prescrip-
tion [12]. The amount of iron intake from supplements
alone was already twice the level of the estimated aver-
age requirement (EAR, 18.5 mg/d) for pregnant women
in Korea [13].
The relationship between maternal hemoglobin (Hb)
concentrations and birth weight has been reported to
be of U-shaped [14,15]. Recent studies have reported
negative associations between high Hb concentrations
(> 130 g/L) and pregnancy outcomes in diverse popu-
lations in China [16,17], US [14,18], Sweden [19], and
Korea [4,20]. A possible explanation for this negative
association is that excessive iron could lead to oxidative
damage [21] and decrease in the absorption of copper
and zinc [22], which are the important micronutrients
for fetal growth.
Previous studies have reported that general iron sup-
plementation have harmful effects on pregnancy out-
comes [23,24]. However, those studies have not taken
into account the levels of iron intake from food. Even
though previous studies in the U.S., [25,26] and England
[27,28] have reported no relation between iron intake
from both food and supplements and pregnancy out-
comes, fetal growth during pregnancy has not been con-
sidered. Therefore, the present study was performed to
investigate the association between maternal iron intake
from both food and supplements at mid-pregnancy.
Fetal biometry was assessed by ultrasonography at mid-
pregnancy. To the best of our knowledge, none of the
studies have employed ultrasonography, which is a reli-
able measurement for fetal growth, to assess the relation




The present investigation was undertaken as a part of
a prospective cohort study of the Mothers and Chil-
dren’s Environmental Health (MOCEH) in South Korea,
established in 2006. Details of the methods of the
MOCEH study have been described previously [29]. The
three local centers involved in the study are located
in Seoul (a metropolitan area), Ulsan (an industrial
area), and Cheonan (a medium-sized urban area). We
recruited pregnant women who were at 12–28 weeks of
gestation and registered at a local center for participa-
tion in the MOCEH study from August 2006 to October
2009. The study sample comprised of pregnant women
at mid-pregnancy of a normal pregnancy, who voluntar-
ily consented to participate in this study after the pur-
pose of the investigation, was explained to them. A total
number of 1563 (537 from Seoul, 491 from Cheonan,and 535 from Ulsan) pregnant women were recruited
after excluding the cases with twins (n = 25) or spontan-
eous abortion (n = 22). Of these, we excluded those who
have not yet delivered babies (n = 399), whose pregnancy
lasted less than 37 or more than 42 weeks (n = 63),
or who had complications associated with pregnancy
(diabetes or hypertension) (n = 29). Among the 1072
subjects, 85 subjects who were without any dietary
intake data and 3 subjects who had energy consumption
of < 500 kcal/d or > 4000 kcal/d were excluded from the
study. Of the 984 subjects, 296 in whom the data related
to fetal biometric measurements (biparietal diameter, ab-
dominal circumference and femur length) was absent at
mid-pregnancy were excluded. In order to investigate
the later effect of maternal nutrients on fetal growth,
353 subjects whose diet intake data at mid-pregnancy
were assessed after the ultrasonography was performed
at mid-pregnancy were also excluded. Thus, a total of
337 women (51 from Seoul, 123 from Cheonan, and 163
from Ulsan) were included in this study. The general
characteristics did not differ significantly between in-
cluded and excluded subjects (data now shown). The
study protocols and consent forms were approved by
three institutional review boards: Ewha Woman’s Uni-
versity School of Medicine, Dankook University Hos-
pital, and Ulsan University Hospital.
Measurements
The participants were interviewed by a trained interviewer
during their visits to local university hospitals, local clinics,
and community public health centers. Information on
demographic factor and socioeconomic factors including
age, height, weight, education, family income, exercise,
smoking behavior, alcohol drinking were obtained by indi-
vidual interviews. Pre-pregnancy body mass index (BMI)
was calculated as weight (kg) divided by height (m2) by
employing self-reported height and weight values before
conception. The sociodemographic factors were catego-
rized as follows: education level (< high school, < university
and ≥ university), family monthly incomes (< US$ 2000,
US$ 2000–4000, and > US$ 4000), passive exposure to
cigarette smoke (yes/no) and parity (n).
As indices for fetal biometry, the biparietal diameter
(BPD), abdominal circumference (AC), and femur length
(FL) were assessed by ultrasonography at mid-pregnancy.
Fetal biometry measurements were carried out at Ewha
Womans University Hospital by a certified ultrasonog-
rapher. The gestational age determined by ultrasound
measurement was obtained from medical records.
Dietary intake at mid-pregnancy was estimated at indi-
vidual medical centers by trained interviewers by
employing a 24-hour recall method. The subjects were
asked to describe all the foods and beverages, which they
had consumed in the past 24 hours before the interview.




Age, y 327 29.9 ± 3.6
Height, cm 324 160.8 ± 4.8
Pre-pregnancy weight, kg 325 56.5 ± 9.7
Pre-pregnancy BMI2, kg/m2 323 21.9 ± 3.5
Education, n (%) 337
< High school 99 (29.4)
< University 59 (17.5)
≥ University 163 (48.4)
No-response 16 (4.7)
Family income, US$/mo, n (%) 337
< 2000 95 (28.2)
2000 - 4000 174 (51.6)
> 4000 43 (12.8)
No-response 25 (7.4)




Urinary cotinine level, μg/g creatinine 316 71.8 ± 444.2









Girls, n (%) 164 (48.7)
Boys, n (%) 159 (47.2)
Gestational age, wk 337 20.0 ± 3.4
Biparietal diameter, cm 334 4.8 ± 1.1
Abdominal circumference, cm 231 16.6 ± 3.8
Femur length, cm 297 3.3 ± 1.0
1 Values are mean ± SD or n (%).
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some items such as snacks, drinks, or extra salt in the
case of subjects, who hardly remembered about what they
had eaten in the past 24 hours. The indicated iron intakes
incorporated both food and supplements sources. Iron in-
take from a 24-hour recall was assessed by using a com-
puterized nutrient intake analysis program (CAN-Pro 3.0,
Korean Nutrition Society, Seoul, Korea). The consump-
tion of nutritional supplements was investigated on the
basis of self-reporting on the same day, when the dietary
questionnaire was administered. Information on type and
brand name of supplements and amounts and frequency
of its use was also directly gathered from the participants.
Maternal total iron intake incorporated both dietary iron
and in the form of supplements.
Statistical analysis
The data are expressed as mean ± SD values (continuous
variables) or as numbers and percentages (categorical
variables). Maternal iron intake and urinary cotinine
levels were log-transformed due to skewed distribution.
In order to examine the difference in fetal biometry
based on their iron intake level, the subjects were di-
vided into tertiles of total iron intake levels (<11.49 mg,
11.49 ~ 17.04 mg, >17.04 mg). The differences in iron in-
take between supplement users and non-supplement
users were analyzed by using student’s t-test. The differ-
ence in fetal biometry according to maternal total iron
intake levels was tested by using the generalized linear
model (GLM) test after controlling for confounding fac-
tors [gestational age at time of ultrasound measurement,
maternal age, maternal height, urinary cotinine level,
pre-pregnancy BMI, parity, family monthly income, sex
of babies and energy intake]. All the statistical tests were
two-tailed and a P value of < 0.05 was considered to be
significant. Statistic analyses were performed with the
SPSS statistical package (version 12.0, SPSS, Chicago, IL,




The participants had a mean age of 29.9 ± 3.6 years and
pre-pregnancy BMI of 21.9 ± 3.5 kg/m2 (Table 1). Ap-
proximately, 28.8% of subjects took iron containing diet-
ary supplements. The mean gestational age at the time of
ultrasound measurement, fetal biparietal diameters, ab-
dominal circumferences, and femur lengths were 20.0 ±
3.4 weeks, 4.8 ± 1.1 cm, 16.6 ± 3.8 cm and 3.3 ± 1.0 cm,
respectively.
Iron intake of subjects
The average iron intake of subjects was 30.9 ± 39.2 mg
(12.5 ± 3.9 mg from foods and 18.4 ± 38.8 mg fromsupplements) (Table 2). Although the total iron intake of
supplement users was six times greater than that of non-
supplement users (76.9 ± 48.5 mg vs. 12.4 ± 3.8 mg),
there was no marked difference in iron intake from food
sources between the two groups. About 99% of the non-
supplement users had iron intake below the RNI
(24 mg), whereas 64.9% of supplement users had iron in-
take above the UL (45 mg).
Table 2 Iron intake at mid-pregnancy according to intake of supplements and total iron intake levels at mid-
pregnancy1
All subjects (n = 337) Supplement users (n = 97) Non-supplement users (n = 240)
n (%) Mean ± SD n (%) Mean ± SD n (%) Mean ± SD
Food,3 mg 12.5 ± 3.9 13.0 ± 3.9 12.4 ± 3.8
Supplements,4 mg 18.4 ± 38.8 63.8 ± 48.3 -
Total iron intake5, mg 30.9 ± 39.2 76.9 ± 48.5a2 12.4 ± 3.8b
< 24 256 (76.0) 12.6 ± 3.9 18 (18.6) 17.9 ± 4.12a 238 (99.2) 12.2 ± 3.6b
24 ~ < 45 18 (5.3) 33.9 ± 6.2 16 (16.5) 34.8 ± 5.9a 2 (0.8) 26.8 ± 3.5a
≥ 45 63 (18.7) 104.4 ± 37.4 63 (64.9) 104.4 ± 37.4 0
1st tertile (< 11.49) 112 (33.3) 9.3 ± 1.7 1 (1.0) - 111 (46.3) 9.2 ± 1.7
2nd tertile (11.49 ~ 17.04) 113 (33.5) 14.0 ± 1.6 8 (8.3) 15.1 ± 1.7a 105 (43.8) 13.9 ± 1.5b
3rd tertile (>17.04) 112 (33.2) 69.7 ± 48.7 88 (90.7) 83.2 ± 46.4a 24 (10.0) 20.2 ± 3.0b
1 Values are mean ± SD or n (%).
2 Significantly different by student’s t-test; Values with different superscript letters within a row are significantly different between supplement uses and
non-supplement users (P < 0.05).
3 Iron intake from food sources only.
4 Iron intake from supplement sources only.
5 Total iron intake from both food and supplement sources.
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from different sources
Fetal biometry and growth were not different according
to the tertile of dietary iron intake adjusting for
confounding factors including iron intake from supple-
ments (data now shown). However, in the babies of
mothers with iron supplementation, biparietal diameter
and abdominal circumference were greater by 0.09 cm
(P =0.012) and 0.39 cm (P = 0.017), respectively, than
the babies of mothers without iron supplementation
after adjusting for confounding factors including diet-
ary iron intake (Table 3).
Fetal biometry and fetal growth according to tertiles of
iron intake levels
In the babies of mothers in the third tertile of iron intake
(>17.04 mg), biparietal diameter, abdominal circumfer-
ence, and femur length were lower by 0.41 cm (P =0.019),
0.41 cm (P = 0.027), and 0.07 cm (P = 0.051), respectively,
than the babies of mothers in the second tertile of iron in-
take (11.49 ~ 17.04 mg) (after adjusting for confounding
factors) (Table 4).Table 3 Fetal biometry at mid-pregnancy according to supple
Total Supplement user
Fetal growth1 n β (SE)
Biparietal diameter, cm 294 1
Abdominal circumference, cm 212 1
Femur length, cm 265 1
1 Adjusted for gestational age at the time of ultrasound measurement, maternal ag
monthly income, sex of babies, energy intake (ln) and dietary iron intake (ln).Discussion
We found that the fetuses of pregnant women with iron
intake in the 3rd tertile (>17.04 mg) had a significantly
lower a biparietal diameter, abdominal circumference,
and femur length than the fetuses of mothers in the sec-
ond tertile of iron intake (11.49 ~ 17.04 mg). About 90%
of the highest tertile were iron supplemental users and
all the mothers who consumed iron above the UL
(45 mg) took supplements containing iron. The average
iron intake of supplement users was 76.9 ± 48.5 mg,
which was three times higher than the RNI (24 mg) and
the source was mainly from the supplements; while the
iron intake from food sources was only 13.0 ± 3.9 mg
which was lower than the EAR (18.5 mg). Fetal biometry
and growth were not different according to the dietary
iron intake adjusting for iron supplementation use, but
were greater in the babies of mothers with iron supple-
mentation than the babies of mothers without iron sup-
plementation adjusting for dietary iron intake. These
results indicate that supplemental iron in pregnancy is
needed for fetal growth but also indicate that excessive
consumption of iron, mainly from the supplements atmental iron intake level at mid-pregnancy
Iron supplement use
s (> 0) Non-supplement users (= 0)
P-value β (SE) P-value R2
0.092 (0.036) 0.012 0.941
0.391 (0.163) 0.017 0.923
0.057 (0.032) 0.077 0.946
e, maternal height, urinary cotinine level (ln), pre-pregnancy BMI, parity, family
Table 4 Fetal biometry at mid-pregnancy according to total iron intake level at mid-pregnancy
Total iron intake (mg)
Total 1st tertile (< 11.49) 2nd tertile (11.49 ~ < 17.04) 3rd tertile (≥ 17.04)
Fetal growth1 n β (SE) P-value β (SE) P-value β (SE) P-value R2
Biparietal diameter, cm 294 −0.03 (0.04) 0.488 1 −0.09 (0.04) 0.019 0.941
Abdominal circumference, cm 212 −0.01 (0.22) 0.958 1 −0.41 (0.18) 0.027 0.922
Femur length, cm 265 −0.01 (0.04) 0.877 1 −0.07 (0.04) 0.051 0.946
1 Adjusted for gestational age at the time of ultrasound measurement, maternal age, maternal height, urinary cotinine level (ln), pre-pregnancy BMI, parity, family
monthly income, sex of babies and energy intake (ln).
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at mid-pregnancy.
Several studies have reported adverse effects of iron
supplements on pregnancy outcomes. Ziaei et al. [23]
reported that SGA birth rate and the number of preg-
nant women with hypertension were significantly higher
in the iron-supplemented group (50 mg/d) when com-
pared with the non-iron-supplemented group (with Hb
level of 132 g/L and above). In their study, no other
differences were observed in the pregnancy outcomes
between both the groups. A randomized trial has re-
vealed that a higher frequency of infant hospitalization
due to convulsions was observed in the routine iron
supplemented group (100 mg/d) when compared with
the selective iron supplemented group [24]. The selective
iron supplemented group was given iron supplementa-
tion if the hematocrit was < 30% and the mother was di-
agnosed to be anemic. These results indicate that a high
dose of general iron prophylaxis without due consider-
ation about the maternal iron status might have a nega-
tive influence on fetus and infant health.
The mechanisms that explain these adverse effects
due to excessive iron intake have not yet been clearly
established; however, several potential mechanisms have
been suggested. Primarily, excessive iron intake could
cause free-radical damage during pregnancy [30-32].
Pregnancy itself is vulnerable to oxidative stress [31].
Free iron catalyzes the transformation of hydrogen perox-
ide to a hydroxyl radical via the Fenton Reaction. Studies
have shown that the levels of free radicals were higher in
pregnant women who consumed iron supplements in
Estonia (36 mg/d) [33] and in the US (19 mg/d) [34] than
those without any consumption of supplements. The free
radicals have been reported to damage cellular DNA, pro-
teins and lipids [35]. According to Takagi et al., the level
of oxidative stress and redox-related molecules was higher
in the placenta in preeclampsia and IUGR than in normal
pregnancy [36]. Secondly, previous studies have reported
that iron supplements could interrupt the absorption of
zinc and copper in pregnant women with Hb ≥132 g/L
[37,38] or with normal Hb levels [39,40]; the reason being
competitive absorption of iron, zinc, and copper from the
small intestine via divalent metal transporter. Moreover, ahigh dose of iron supplements (>30 mg/day) can fre-
quently lead to gastrointestinal problems such as consti-
pation, diarrhea, nausea and vomiting [41].
Our results indicate that iron intake from food in preg-
nant women was inadequate but supplement users con-
sumed an excessively high amount of iron from the
supplements. It is evident from the previous reports that
iron requirements during pregnancy cannot be satisfied
by iron from foods alone and iron supplementation is ne-
cessary during pregnancy [42] and is helpful for adequate
fetal growth. In our study, total iron intake was lower
than the recommended level in women who did not con-
sume iron supplements and amongst the women with
iron intake below the RNI (24 mg), only 7% of them took
iron supplements. In contrast, supplement users had iron
intake of 76.9 ± 48.5 mg, which was three times higher
than the RNI (24 mg) and the iron intake exceeded the
UL in 65% of the supplement users. Some supplement
users also took prescribed iron supplements in addition
to over-the-counter multi-vitamin supplements, while
others took higher dose of iron supplements than the
prescribed dosage. This raises a potential problem that
some pregnant women, non-anemic, non-iron deficient,
might consume unnecessarily high amounts of general
iron prophylaxis during pregnancy.
In the case of non-anemic pregnant women in Mexico,
high dose of iron-supplementation (60 mg/day) was re-
lated to high rates of hemoconcentration (Hb > 145 g/L),
which was further associated with a relatively high risk
of low birth weight and premature delivery [43]. How-
ever, a low dose of iron supplement (30 mg/d) was sig-
nificantly associated with a higher mean birth weight, a
lower incidence of low-birth-weight infants and lower
incidence of preterm low-birth-weight infants in 513
iron-replete non-anemic pregnant women in the U.S.
Daily supplementation [44]. Therefore, a low dose of
iron supplements (30 mg/d or 120 mg/wk) may be more
beneficial for fetal growth than a high dose of iron and
proper advice about iron supplementation should be
provided by a nutritionist or health professionals to pre-
vent excessive iron intake by pregnant women.
Iron is necessary for normal fetal growth and develop-
ment and the physiologic iron requirements during the
Hwang et al. Nutrition Journal 2013, 12:38 Page 6 of 7
http://www.nutritionj.com/content/12/1/38second half of pregnancy cannot be achieved by dietary
iron only. Iron supplementation during pregnancy con-
sistently increase serum ferritin and hemoglobin and de-
crease the prevalence of iron deficiency anemia. With
consideration of negative influences of iron such as in-
creased oxidative stress and competitive absorption with
other divalent metals during pregnancy, the lowest ef-
fective dose of iron supplementation based on women’s
iron status should be recommended. Milman [42] sug-
gested that individual iron prophylaxis according to
serum ferritin status, indicative of risk for iron defi-
ciency, should be preferred to general prophylaxis. In
addition, bioavailability of iron from animal foods is
higher than iron from plant foods due to high compos-
ition of hem iron and meat factors. Components in food
such as phytate and polyphenols reduce the absorption
of both dietary and supplementary iron. Maximum ab-
sorption of ferrous iron from supplementation can
obtained when the tablets is taken between the meals ra-
ther than at or after a meal [45].
Our present study was associated with several limitations.
Firstly, maternal iron status in blood was not assessed in
the present study although maternal hematological param-
eters such as, Hb and hematocrit levels are important ones
to be considered when we study the effect of maternal
iron intake on fetal growth [46]. Secondly, the employed
dietary intake and supplements were investigated for only
a single time. A 24-hour recall may be insufficient to pos-
tulate that the values are from a usual daily intake due to
large intra-individual variability. Although measurements
of dietary intake based on a single 24–hour recall per indi-
vidual of the large sample size can provide a good prob-
able estimate of the mean for a study population, the
standard deviation will be greatly overestimated. Further-
more, the random within-person variation may reduce the
strength of associations under the study, possibly to the
point of being undetectable. However, trained dietitians
employed standard protocols in helping the subjects in
reporting their daily diet to minimize plausible errors.
Third, recruitment from voluntary participation as well
as non-participation or non-responses might have intro-
duced a selection bias. But, general characteristics did not
differ significantly between included and excluded subjects
and high recruitment rate in main centers of the study
minimizes the chance that results were distorted by selec-
tion bias. To the best of our knowledge, this is the first
study to investigate the association between maternal total
iron intake and fetal growth in a relatively large sample, as
assessed by ultrasonography. In addition, this work had
certain advantages over previous studies because it was
a multi-center prospective cohort study that utilized a
strict protocol. Moreover, possible confounders such as
gestational age at the time of ultrasound measurement,
maternal age, maternal height, urinary cotinine level, pre-pregnancy BMI, parity, family monthly income, sex of
babies and energy intake were all accounted for the
analyses.
Conclusion
In conclusion, excessive maternal iron intake at mid-
pregnancy is associated with reduced fetal growth. Our
results suggest that iron supplements of a low dose in-
stead of high dose may be a better option for the preg-
nant women. Further studies are needed to assess the
risks or benefits of total iron intake according to mater-
nal iron status in pregnant women, and to investigate
the relationship of maternal iron intake with birth out-
comes and postnatal growth in the present study
group.
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